Free Trial

627 Shares in Synopsys, Inc. (NASDAQ:SNPS) Acquired by Crestwood Advisors Group LLC

Synopsys logo with Computer and Technology background

Crestwood Advisors Group LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 627 shares of the semiconductor company's stock, valued at approximately $269,000.

A number of other hedge funds also recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of Synopsys during the 4th quarter worth about $583,608,000. GAMMA Investing LLC raised its position in shares of Synopsys by 54,286.0% during the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company's stock worth $513,116,000 after acquiring an additional 1,194,292 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Synopsys by 21.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company's stock worth $2,864,933,000 after acquiring an additional 1,045,326 shares in the last quarter. Pictet Asset Management Holding SA raised its position in shares of Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after acquiring an additional 673,837 shares in the last quarter. Finally, Capital Research Global Investors acquired a new stake in shares of Synopsys during the 4th quarter worth about $239,864,000. Institutional investors and hedge funds own 85.47% of the company's stock.

Insider Activity at Synopsys

In related news, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the transaction, the executive directly owned 1,485 shares in the company, valued at $699,746.85. This trade represents a 85.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the sale, the chief executive officer owned 71,589 shares of the company's stock, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,686 shares of company stock valued at $13,001,048. Insiders own 0.62% of the company's stock.

Synopsys Trading Down 1.3%

Synopsys stock traded down $8.13 during trading on Friday, hitting $601.55. The company's stock had a trading volume of 1,819,768 shares, compared to its average volume of 1,443,806. The stock has a market capitalization of $93.34 billion, a price-to-earnings ratio of 43.43, a P/E/G ratio of 4.07 and a beta of 1.12. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. The stock's fifty day moving average is $516.09 and its 200 day moving average is $486.19. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $618.49.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. Synopsys's revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.00 earnings per share. As a group, equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on SNPS shares. The Goldman Sachs Group started coverage on Synopsys in a research report on Thursday, July 10th. They set a "buy" rating and a $620.00 target price on the stock. Bank of America raised their price target on Synopsys from $575.00 to $625.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Rosenblatt Securities raised their price target on Synopsys from $625.00 to $650.00 and gave the stock a "buy" rating in a research note on Friday. Mizuho cut their price target on Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Finally, KeyCorp boosted their price objective on shares of Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $622.33.

Check Out Our Latest Stock Report on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines